Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial

Trial design: Human papillomavirus infection causes verruca vulgaris. CDK9 inhibitor FIT039 inhibits DNA virus proliferation in animal models. We conducted a multicenter, single-blind, placebo-controlled, randomized phase I/II clinical trial evaluating the safety and efficacy of FIT039 against verru...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Takashi Nomura (Awdur), Eriko Sumi (Awdur), Gyohei Egawa (Awdur), Saeko Nakajima (Awdur), Eiko Toichi (Awdur), Nana Inoue (Awdur), Mami Shibuya (Awdur), Natsuko Okamoto (Awdur), Tsuyoshi Mitsuishi (Awdur), Ryuji Uozumi (Awdur), Harue Tada (Awdur), Takayuki Nakagawa (Awdur), Nobuhiro Kusuba (Awdur), Aika Okuno (Awdur), Chihiro Shimizuhira (Awdur), Makiko Ishikawa (Awdur), Shiro Tanaka (Awdur), Masatoshi Hagiwara (Awdur), Kenji Kabashima (Awdur)
Fformat: Llyfr
Cyhoeddwyd: Elsevier, 2021-09-01T00:00:00Z.
Pynciau:
Mynediad Ar-lein:Connect to this object online.
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Rhyngrwyd

Connect to this object online.

3rd Floor Main Library

Manylion daliadau o 3rd Floor Main Library
Rhif Galw: A1234.567
Copi 1 Ar gael